TR-338: Erythromycin stearate (643-22-1)
Study Results
Chronic Bioassay Level of Evidence
Rats | |
---|---|
View
|
|
View
|
Mice | |
---|---|
View
|
|
View
|
Genetic Toxicology
Mammalian Cell Mutagenicity |
---|
View
|
Mammalian Cell Cytogenetics | |
---|---|
CA | SCE |
|
|
Bacterial Mutagenicity |
---|
View
|
Publications
TR-338
Toxicology and Carcinogenesis Studies of Erythromycin Stearate (CASRN 643-22-1) in F344/N Rats and B6C3F1 Mice (Feed Studies)
Study Data
Toxicity and Carcinogenicity Studies
Evaluation of the Chronic Toxicity and Carcinogenicity of Erythromycin Stearate (643-22-1) in Male F344 Rats Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Erythromycin Stearate (643-22-1) in Female F344 Rats Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Erythromycin Stearate (643-22-1) in Male B6C3F1 Mice Exposed via Dosed Feed
Evaluation of the Chronic Toxicity and Carcinogenicity of Erythromycin Stearate (643-22-1) in Female B6C3F1 Mice Exposed via Dosed Feed
Genetic Toxicology Studies
Cytogenetic Study of Erythromycin Stearate in Chinese Hamster Ovary Cell Chromosome Aberrations Test
Genetic Toxicity Evaluation of Erythromycin Stearate in Salmonella/E.coli Mutagenicity Test or Ames Test. Study 457939
Summary Data
- G06 - Ames Summary Data (137 KB)